Baird Medical (BDMD) acting CFO Li Jie Clara files Form 3

Rhea-AI Filing Summary

Baird Medical Investment Holdings Ltd filed an initial insider ownership report for Li Jie Clara, who serves as Acting Chief Financial Officer. This Form 3 excerpt lists her as a reporting person but shows no reported transactions or derivative positions in the summarized data.

Key Figures

Insider transactions reported: 0 transactions Buy and sell counts: 0 buys, 0 sells Derivative transactions: 0 derivative transactions

3 metrics

Insider transactions reported 0 transactions Form 3 transactionSummary for Li Jie Clara

Buy and sell counts 0 buys, 0 sells Form 3 transactionSummary fields buyCount and sellCount

Derivative transactions 0 derivative transactions Form 3 derivativeTransactionCount for Li Jie Clara

Key Terms

Form 3, Acting Chief Financial Officer, reporting person

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Acting Chief Financial Officer financial

""officer_title": "Acting Chief Financial Officer""

reporting person regulatory

""reportingPersons": [ { "name": "Li Jie Clara""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 04/15/2026 - 06:10 AM Learn about SEC filing dates

FAQ

Who is the reporting person in Baird Medical (BDMD) Form 3?

The reporting person is Li Jie Clara, identified as the Acting Chief Financial Officer of Baird Medical Investment Holdings Ltd. She is listed as an officer and not as a director or ten percent owner in this insider filing data excerpt.

What does this BDMD Form 3 excerpt show about insider transactions?

The excerpt shows no reported transactions for Li Jie Clara. Transaction counts for buys, sells, exercises, gifts, tax withholding, restructuring, and derivative transactions are all listed as zero, indicating no insider trading activity in this specific data snapshot.

Does Li Jie Clara report any derivative securities in this BDMD Form 3?

No, the provided data shows an empty derivativeSummary, indicating that no derivative positions such as options or warrants are listed for Li Jie Clara in this Form 3 excerpt. All derivative-related transaction counts are also reported as zero here.

How many holdings entries appear in this Baird Medical Form 3 data?

The holdingEntries field in the transaction summary is zero in this excerpt. That means no specific holdings lines are itemized in the structured data provided, even though Li Jie Clara is identified as a reporting person for the issuer.

What does the net buy/sell direction indicate in BDMD’s Form 3 data?

The netBuySellDirection is marked as “neutral,” with netBuySellShares at zero. This reflects that there were no net purchases or sales reported for Li Jie Clara in the summarized Form 3 insider filing data supplied.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Li Jie Clara

(Last) (First) (Middle)

15 RONG TONG STREET

(Street)

GUANGZHOU GUANGDONG 510030

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/15/2026

3. Issuer Name and Ticker or Trading Symbol
Baird Medical Investment Holdings Ltd [ BDMD ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Acting Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Li Jie Clara	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)